We invest heavily in research and manufacture of biosimilars that are off patent or close to patent expiry.
By working collaboratively with multiple manufacturing entities, investing in technology transfer agreements and our own manufacturing capabilities we can offer flexibility in our supply chain that caters to healthcare providers around the world.
We strategically identify and work closely with world producers, offering scale up opportunities via a multi faceted approach to Pharmaceutical actives. By knowing and understanding the market we set trends and standards of quality that are acceptable throughout the world. Working closely with FDA, MHRA, EMA, PMDA & others allows high standards of our products to meet client expectations
Polyethylene glycol, PEG hydroxyl or PEG alcohol are suitable for activation into PEG derivatives. We offer PEGS of a high quality with little or no diol content. Our flexibility and expertise in PEG technology is based on many years of industry experience. We offer material in gram scale for R&D to multi kg GMP standard material for all your scale up projects.